...
首页> 外文期刊>Journal of Ethnopharmacology: An Interdisciplinary Journal Devoted to Bioscientific Research on Indigenous Drugs >Adjuvant effects of Astragalus saponins Macrophyllosaponin B and Astragaloside VII.
【24h】

Adjuvant effects of Astragalus saponins Macrophyllosaponin B and Astragaloside VII.

机译:黄芪总皂苷B和黄芪甲苷的佐剂作用。

获取原文
获取原文并翻译 | 示例
           

摘要

AIM OF THE STUDY: The present study was undertaken to evaluate the hemolytic activities of two immunomodulator Astragalus saponins [Macrophyllosaponin B (MacB) from Astragalus oleifolius DC. and Astragaloside VII (Ast VII) from Astragalus trojanus Stev.], and their adjuvant potentials on the cellular and humoral immune responses of Swiss albino mice against BSA. MATERIALS AND METHODS: The hemolytic activity of Mac B and Ast VII was determined using 0.5% rabbit red blood cell. For adjuvant activity, Swiss albino mice were immunized subcutaneously with BSA 100 mug alone or with BSA 100 mug dissolved in saline containing Ast VII (30, 60, 120 and 240 mug), Mac B (30, 60, 90 and 120 mug) or Freund's adjuvant on Days 1 and 15. Sera and splenocytes were collected 2 weeks after the last immunization for concanavalin A (Con A)-, lipopolysaccharide (LPS)- and BSA-stimulated splenocyte proliferation assay and measurement of BSA-specific antibodies in serum. RESULTS: Mac B and Ast VII showed a slight hemolytic effect, with 0.42% and 0.54% values, respectively, at the highest concentration of 500 mug/ml. Mac B and Ast VII significantly enhanced the Con A-, LPS-, and BSA-induced splenocyte proliferation in the BSA-immunized mice especially at 120 and 240 mug (P<0.001), and 60, 90 and 120 mug (P<0.05, P<0.01 or P<0.001) doses, respectively. BSA-specific IgG, IgG1 and IgG2b antibody titers in serum were also significantly enhanced by Ast VII (120 mug), Mac B (90 mug) and Freund's as compared to the control group (P<0.01 or P<0.001). Moreover, the IFN-gamma and IL-4 levels in the sera were detected using ELISA two weeks after the last immunization. Ast VII and Mac B were also found to stimulate IFN-gamma production such as Freund's, two weeks after the last immunization at doses of 120 mug and 90 mug, respectively, as compared to the control. CONCLUSION: Results show that Ast VII and Mac B generate important specific antibody and cellular response against BSA in mice, proving their potentials as a new class saponin adjuvant.
机译:研究目的:进行本研究以评估两种免疫调节剂黄芪总皂苷[Macrophyllosaponin B(MacB),来自黄芪DC]的溶血活性。和来自Astragalus trojanus Stev。的黄芪甲苷VII(Ast VII),以及它们对瑞士白化病小鼠针对BSA的细胞和体液免疫反应的佐剂潜力。材料与方法:用0.5%的兔红细胞测定Mac B和Ast VII的溶血活性。为了具有佐剂活性,仅用BSA 100杯或溶解在含Ast VII(30、60、120和240杯),Mac B(30、60、90和120杯)的盐水中的BSA 100杯皮下免疫瑞士白化病小鼠。在第1天和第15天的弗氏佐剂上次免疫伴刀豆球蛋白A(Con A),脂多糖(LPS)和BSA刺激的脾细胞增殖测定并测量血清中BSA特异性抗体后2周,收集血清和脾细胞。结果:Mac B和Ast VII在500杯/毫升的最高浓度下表现出轻微的溶血作用,分别为0.42%和0.54%。 Mac B和Ast VII显着增强了BSA免疫小鼠中Con A-,LPS-和BSA诱导的脾细胞增殖,尤其是在120和240杯(P <0.001)以及60、90和120杯(P <0.05)时,P <0.01或P <0.001)剂量。与对照组相比,Ast VII(120马克杯),Mac B(90马克杯)和Freund氏菌也显着增强了血清中BSA特异性IgG,IgG1和IgG2b抗体的滴度(P <0.01或P <0.001)。此外,在最后一次免疫后两周,使用ELISA检测血清中的IFN-γ和IL-4水平。与对照相比,在最后一次免疫后两周,分别以120杯和90杯的剂量,Ast VII和Mac B也能刺激IFN-γ的产生,例如弗氏。结论:结果表明Ast VII和Mac B在小鼠中产生了重要的针对BSA的特异性抗体和细胞应答,证明了它们作为新型皂苷佐剂的潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号